Publications
Peer-Reviewed Journals
- For the complete list of the publications please visit: PubMed link.
Selected Publications
-
PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer. Pellizzari S, Bhat V, Athwal H, Cescon DW, Allan AL, Parsyan A. Radiat Oncol. 2024 Feb 16;19(1):24
-
Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer. Parsyan A, Cruickshank J, Hodgson K, Wakeham D, Pellizzari S, Bhat V, Cescon DW. Breast. 2021 Aug;58:6-9.
-
mRNA helicases: the tacticians of translational control. Parsyan A, Svitkin Y, Shahbazian D, Gkogkas C, Lasko P, Merrick WC, Sonenberg N. Nat Rev Mol Cell Biol. 2011 Apr;12(4):235-45
-
The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis. Parsyan A, Shahbazian D, Martineau Y, Petroulakis E, Alain T, Larsson O, Mathonnet G, Tettweiler G, Hellen CU, Pestova TV, Svitkin YV, Sonenberg N. Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22217-22.
-
p53-dependent translational control of senescence and transformation via 4E-BPs. Petroulakis E, Parsyan A, Dowling RJ, LeBacquer O, Martineau Y, Bidinosti M, Larsson O, Alain T, Rong L, Mamane Y, Paquet M, Furic L, Topisirovic I, Shahbazian D, Livingstone M, Costa-Mattioli M, Teodoro JG, Sonenberg N. Cancer Cell. 2009 Nov 6;16(5):439-46.
-
MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Mathonnet G, Fabian MR, Svitkin YV, Parsyan A, Huck L, Murata T, Biffo S, Merrick WC, Darzynkiewicz E, Pillai RS, Filipowicz W, Duchaine TF, Sonenberg N. Science. 2007 Sep 21;317(5845):1764-7
Book Chief Editing
Parsyan, A. (2014) Translation and Its Regulation in Cancer Biology and Medicine. Springer.
